In 2023, the surgical stapler market stood at USD 5.3 billion, with a projected growth rate of 6.9% from 2024 to 2030, culminating in a value of USD 8.4 billion by 2030. This growth can be credited to the increasing preference for staplers over sutures.

With technical improvement, several industry companies are commercializing staplers, to fulfill the growing need for doctors throughout the globe. Such devices are used across several medicine branches, for instance, thoracic, gynecology, and gastrointestinal operations, along with tissue & wound management procedures.

Because of the surge in the count of medical procedures, increasing acceptance of advanced techs, and rising popularity of non-invasive approaches, North America is the dominator of the sector.

The high overweight ness occurrence, presence of all key medicinal consumable businesses, and regulatory sanction for less-invasive procedures are also accountable for the substantial share of this region in the market. Additionally, dedicated devices are now obtainable for thoracoscopic and laparoscopic procedures that use medical staplers.

The growth of this sector will be driven by continued technical progress. Medical device manufacturers are focused on developing staplers with the latest safety features, ergonomic design, and precision in order to meet changing healthcare needs. The stapling designs are also improving as a result of the use of advanced imaging technologies, robots, and AI.

Moreover, their minuscule requirement of cleaning, disinfecting, and maintaining devices which has also come down along with the trend of isolated use of sterile ones as well should be highlighted. Giving greater attention to the decrease in the incidents of catching infections in hospitals and to the improved patient flow in healthcare facilities will open the way to develop this industry.

In the future, ASCs will be the go-to model of delivery based on the end user. The limited financial resources that mainly characterize the economy in developed and under-developed countries represent the counterpart for that.

Therefore, on the patients, ASCs with rapid turnover and minimized waiting times lead to faster processes, eventually making them more likely to go for those facilities.

Hospitals will endure to account for the major share in this segment during the projection period. The majority of the operations, particularly the complex, open ones, are done at hospitals, as ASCs and independent clinics commonly do not have the specialists or the equipment to manage such procedures.

Furthermore, only huge and well-funded hospitals can have enough money for expensive medical robots, which is why MISs are also primarily performed here.

Hence, with technical improvement, several industry companies are commercializing staplers, to fulfill the growing need for doctors throughout the globe, which is driving the market growth.


SOURCE: P&S Intelligence